Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Bath & Body Works (NYSE:BBWI - Get Rating) issued an update on its FY 2022 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $4.300-$4.700 for the period, compared to the Thomson Reuters consensus estimate of $4.280. The company issued revenue guidance of -.Bath & Body Works also updated its Q1 2022 guidance to $0.470-$0.550 EPS.

Shares of Bath & Body Works stock opened at $45.59 on Wednesday. The firm has a market cap of $11.75 billion, a P/E ratio of 9.27, a P/E/G ratio of 1.17 and a beta of 1.80. The firm has a 50 day simple moving average of $56.61 and a 200 day simple moving average of $64.99. Bath & Body Works has a fifty-two week low of $43.18 and a fifty-two week high of $82.00.

Bath & Body Works (NYSE:BBWI - Get Rating) last issued its quarterly earnings results on Tuesday, February 22nd. The company reported $2.30 earnings per share for the quarter, beating analysts' consensus estimates of $2.27 by $0.03. Bath & Body Works had a net margin of 14.13% and a negative return on equity of 125.13%. The business had revenue of $3.03 billion during the quarter, compared to analyst estimates of $2.96 billion. During the same quarter last year, the business posted $1.96 earnings per share. Bath & Body Works's revenue for the quarter was up 11.4% compared to the same quarter last year. Equities analysts anticipate that Bath & Body Works will post 4.62 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 4th. Shareholders of record on Friday, February 18th were paid a $0.20 dividend. The ex-dividend date was Thursday, February 17th. This is a boost from Bath & Body Works's previous quarterly dividend of $0.15. This represents a $0.80 dividend on an annualized basis and a yield of 1.75%. Bath & Body Works's dividend payout ratio (DPR) is presently 16.26%.

A number of equities analysts have issued reports on BBWI shares. Robert W. Baird reduced their price objective on shares of Bath & Body Works from $90.00 to $75.00 in a research note on Friday, February 25th. Wells Fargo & Company lifted their price target on shares of Bath & Body Works from $80.00 to $85.00 and gave the stock an overweight rating in a research report on Thursday, November 18th. The Goldman Sachs Group raised shares of Bath & Body Works from a buy rating to a conviction-buy rating in a research report on Wednesday, January 19th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Bath & Body Works from $86.00 to $78.00 and set a buy rating on the stock in a research note on Thursday, February 24th. Finally, Zacks Investment Research lowered shares of Bath & Body Works from a strong-buy rating to a hold rating in a research note on Tuesday, January 11th. Three investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of Buy and a consensus target price of $80.28.

Institutional investors have recently modified their holdings of the company. Peapack Gladstone Financial Corp bought a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $209,000. Forum Financial Management LP bought a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $290,000. Bank Julius Baer & Co. Ltd Zurich lifted its holdings in shares of Bath & Body Works by 94.6% during the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 5,365 shares of the company's stock worth $374,000 after acquiring an additional 2,608 shares during the period. JustInvest LLC lifted its holdings in shares of Bath & Body Works by 20.5% during the 4th quarter. JustInvest LLC now owns 5,798 shares of the company's stock worth $405,000 after acquiring an additional 987 shares during the period. Finally, MML Investors Services LLC lifted its holdings in shares of Bath & Body Works by 7.4% during the 4th quarter. MML Investors Services LLC now owns 14,407 shares of the company's stock worth $1,005,000 after acquiring an additional 991 shares during the period. 92.23% of the stock is owned by institutional investors.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read MoreGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)3 Attractive Stocks with P/E Ratios Under 10Got Stagflation Worries? 3 Stocks to Help You Get Around ItThe 3 Best Biotech Stocks to Buy in MarchTime to Take Some Twitter Stock The Bottom Is In For Desktop Metal 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Each market day you'll get a one-minute market summary to help you invest wisely.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.